Actinogen pivotal Alzheimer’s disease trial database lock milestone - topline results on track for mid-November
New academic publication highlights the strong science behind oral Xanamem's brain cortisol-control mechanism New academic publication highlights the strong science behind oral Xanamem's brain cortisol-control mechanism
Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.comSummary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.